Co-Op, Drug Product Analytical Development
We are looking for a co-op to help us develop a nanoparticle-based drug delivery system for messenger RNA. Nanomedicine technology is one of the most exciting emerging areas of drug delivery today. Pursuing this technology involves a major focus on characterizing interfacial and colloidal properties together with understanding how the messenger RNA molecule itself affects pharmaceutical attributes of the nanoparticle system. We are looking for a candidate who is enthusiastic and curious with a strong interest in learning laboratory instrumentation and data interpretation aimed at nanoparticle characterization and stabilization. The position will be laboratory-based (Cambridge) with a strong emphasis on applying advanced biophysical methodologies, experimental design and data analysis. Chemistry, Biochemistry, Chemical Engineering, and Pharmaceutical Sciences majors are all encouraged to apply.
Here's What You'll Do:
- Learn about RNA structure function, pharmaceutical development, and drug delivery with nanoparticles
- Learn and apply biophysical instrumentation for nanoparticle sizing and surface characterization
- Perform laboratory instrumental analysis
- Perform formulation preparation, characterization and stability studies
- Computational analysis of thermodynamic, biophysical and stability data
Here's What You'll Bring to the Table:
- Minimum GPA of 3.4
- Currently Enrolled Junior or Senior
- Must be curious, eager, open to learning, and independent
Here's What We'll Bring to the Table:
- Daily on-site catered lunches
- Free parking, monthly subway pass or a subsidized commuter rail pass
- Healthcare coverage includes medical offered through BCBS (HMO/PPO), dental, and vision offered through VSP
- Accrued paid vacation
Why join Moderna?
We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching. It could transform not only how certain diseases are treated but also how medicines are discovered, developed and manufactured - at a breadth, scale and speed not common in the biopharma industry.
Since our founding in 2011, we have built the industry's leading mRNA technology platform, the infrastructure to accelerate drug discovery and speed early development, a rapidly expanding pipeline, and an unparalleled team. Our development pipeline includes development candidates for mRNA-based vaccines and therapies spanning several therapeutic areas, and we have multiple clinical trials already underway with other development candidates progressing toward the clinic. In addition, we have a number of discovery programs that are advancing toward the development stage.
We invite you to explore our site to learn more about our company and how we are advancing the promise of mRNA science to improve health and impact lives around the world.
Deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.
Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.